Drug Profile
ARO 01
Alternative Names: ARO-01Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator AROMICS
- Class Antidementias
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Alzheimer's disease
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Alzheimer's-disease in Spain
- 10 Aug 2016 ARO 01 is available for licensing as of 10 Aug 2016. http://www.aromics.es/
- 10 Aug 2016 Early research in Alzheimer's disease in Spain (unspecified route)